Ch. du Vernay 14a
CH-Vaud
1196 格兰德
info@neumarz.com
+41.21.561.34.96
返回

公平性意见:其认证范围及未涵盖的内容

简而言之: A fairness opinion tells a board whether the consideration in a transaction is fair to a specific constituency from a financial point of view, as of a stated date and under a defined set of assumptions. It does not certify solvency, does not identify the best available price, and says nothing about whether the deal is strategically sound. Delaware’s courts turned the fairness opinion into a near-standard fixture of deal process after the board in Smith v. Van Gorkom was found to have breached its duty of care in part because it approved a buyout without one. Later rulings went further, penalizing bankers whose staple financing arrangements compromised the independence behind the opinion. Read correctly, the letter is one input into a board’s fiduciary process. It is not a substitute for that process.

What the Letter Actually Says

A fairness opinion is a written analysis, typically prepared by an investment bank or an independent valuation firm, concluding whether the consideration to be paid or received in a merger, acquisition, buyback, or similar transaction is fair to a defined group, usually shareholders, from a financial point of view as of a specific date. The phrasing is deliberate. The opinion addresses one narrow question: given the valuation methodologies applied and the assumptions fed into them, does the price fall within a defensible range of fairness. It is not required by law in most jurisdictions, yet it has become close to customary in sale-of-control transactions involving public companies, management buyouts, recapitalizations, and related-party transfers, because boards and their counsel treat it as part of a defensible record.

Why Boards Ask for One

The practice traces to a specific case. In Smith v. Van Gorkom, the Delaware Supreme Court reviewed a 1980 leveraged buyout of TransUnion in which chairman Jerome Van Gorkom proposed a $55-per-share price after consulting only the company’s CFO, without commissioning outside valuation work. The court found “the record is devoid of any competent evidence that $55 represented the per share intrinsic value of the Company,” and held the board liable for breaching its duty of care, noting the directors could have avoided that exposure with a fairness opinion from someone positioned to know the firm’s value. The ruling rattled boardrooms nationally, drove up director and officer insurance premiums, and prompted Delaware’s legislature to permit charter provisions exculpating directors from certain duty-of-care claims. Its practical legacy, though, was to make the fairness opinion a standard input for satisfying the duty of care under the business judgment rule, and, in a sale of control, the heightened Revlon obligation to pursue the best value reasonably available to shareholders.

Where the Opinion’s Authority Ends

The scope of a fairness opinion is narrower than boards and counterparties sometimes assume. It renders a view on financial fairness within a range built from comparable transactions, trading multiples, and discounted cash flow assumptions selected by the advisor. It does not opine on whether the company will remain solvent after the transaction closes, a separate question addressed by a solvency opinion. It does not identify the highest price obtainable, nor does it substitute for a competitive process; a solvency opinion and a fairness opinion answer distinct questions and are not interchangeable. It offers no legal, tax, accounting, or regulatory advice, and it does not recommend how shareholders should vote. Perhaps most importantly, a fairness opinion cannot repair a flawed sale process; it is meant to complement good governance, not compensate for its absence.

A fairness opinion typically addresses A fairness opinion does not address
Whether consideration is fair from a financial point of view, as of a stated date Whether the company will be solvent after closing
Whether the price falls within a range built from accepted valuation methods Whether the price is the highest reasonably obtainable
Financial reasonableness of the transaction structure Legal, tax, accounting, or regulatory soundness
Support for a board’s fiduciary record Strategic merit, or how shareholders should vote

When the Adviser Has Skin in the Game

Delaware’s courts have spent the past fifteen years narrowing the credibility gap between an opinion and the incentives behind it. In the 2011 Del Monte Foods sale, the Court of Chancery criticized Barclays for advising the seller’s board while simultaneously arranging financing for the buyer. The starker case came out of the sale of Rural/Metro Corporation to Warburg Pincus, where RBC Capital Markets pursued staple financing for the buyer while advising Rural’s board, without disclosing that conflict, and structured its valuation work in a way the trial court found misleading. The Delaware Supreme Court upheld a judgment of nearly $76 million against RBC for aiding and abetting the board’s breach of fiduciary duty, while explicitly declining to cast bankers as “gatekeepers” responsible for policing every board decision. The court’s guidance to directors was direct: they need to be active and reasonably informed in identifying and responding to an adviser’s actual or potential conflicts, not merely to accept an opinion at face value.

Disclosure as the Regulatory Answer

Regulators addressed the same conflict from the securities side. FINRA’s fairness-opinion rule (originally NASD Rule 2290, since succeeded by Rule 5150) requires member firms, once an opinion is headed for public shareholders, to disclose whether their fee is contingent on the deal closing, whether the firm has a material relationship with any party to the transaction from the prior two years, whether information underlying the opinion was independently verified, and whether the opinion was reviewed by an internal fairness committee. None of these disclosures make the opinion itself more rigorous. They make the conflicts, if any exist, visible to the people relying on the letter.

What This Means for a Board’s Process

None of this diminishes the fairness opinion’s value. It remains a meaningful discipline: it forces a documented valuation exercise, creates a record that a board considered the financial terms with expert input, and gives directors a defensible basis for the business judgment protections courts extend to informed decisions. But its value depends entirely on the independence of the party issuing it and the rigor behind the number. A board that treats the letter as a formality, obtained from whichever bank is already running the deal, inherits the exact risk the opinion was meant to retire.

Neumarz advises Swiss and cross-border boards on exactly this distinction, providing independent fairness opinions built on our own valuation work rather than a deal team’s incentives, so that the letter a board receives holds up to the scrutiny a transaction eventually attracts.

参考资料

  1. Stout, “Fairness Opinions: A Brief Primer,” https://www.stout.com/en/insights/article/fairness-opinions-brief-primer
  2. Wikipedia, “Smith v. Van Gorkom,” https://en.wikipedia.org/wiki/Smith_v._Van_Gorkom
  3. Wikipedia, “Fairness opinion,” https://en.wikipedia.org/wiki/Fairness_opinion
  4. Morris James LLP, “The Delaware Supreme Court Upholds $76 Million Judgment Against RBC for Rural/Metro Sale,” https://morrisjames.com/blogs-Delaware-Business-Litigation-Report,RBC-Rural-Metro-Judgment-Upheld
  5. Sofer Advisors, “What Is a Fairness Opinion in Mergers and Acquisitions?,” https://soferadvisors.com/insights/valuation/what-is-a-fairness-opinion-in-mergers-and-acquisitions/
  6. FINRA, “SEC Approves New NASD Rule 2290 Regarding Fairness Opinions,” https://www.finra.org/rules-guidance/notices/07-54
Orsen Okami
奥森-奥卡米
https://www.kainjoo.com
Kainjoo 是一家品牌科技公司,为受监管行业提供符合“改善”(Kaizen)和“六西格玛”(Six Sigma)标准的品牌活动。.

Leave a Reply

您的邮箱地址不会被公开。 必填项已用 * 标注

法律声明

投资涉及高风险。

投资者在决定是否投资该提案之前,应仔细考虑向您提供的投资者协议中描述的风险和所有其他信息。

参与和投资是投机性活动,涉及高金融风险。在评估对 Neumarz(Allegory Capital & Kainjoo SA 旗下品牌)及其活动的投资时,应考虑的某些风险因素包括但不限于以下所列因素。

其中任何一项或多项风险都可能对 Allegory Capital & Kainjoo SA 旗下品牌 Neumarz 的任何投资价值,以及 Allegory Capital & Kainjoo SA 旗下品牌 Neumarz 的业务、财务状况或经营业绩产生重大不利影响。

投资者可能会损失其在 Allegory Capital & Kainjoo SA 旗下品牌 Neumarz 的全部或部分投资。

Allegory Capital & Kainjoo SA 旗下品牌 Neumarz 高管和董事目前不了解的其他风险和不确定因素也可能对当前活动产生不利影响。以下信息并非对 Allegory Capital & Kainjoo SA 旗下品牌 Neumarz 所面临风险的详尽总结。也无意按任何假定的优先顺序排列。与 Allegory Capital & Kainjoo SA 旗下品牌 Neumarz 的业务有关的风险主要包括

(a) 无法保证 Allegory Capital 或 Kainjoo SA 将在未来赚取利润或持续盈利;

(b) 无法保证 Allegory Capital 或 Kainjoo SA 将获得足够的资金用于未来运营或履行其在当前协议下的义务;

(c) 投资固有的风险,包括:(i) 这些资产的估值可能会大幅波动;(ii) 风险投资的监管制度不确定,新的法规或政策可能会对投资的发展产生重大不利影响;(iii) 企业的进一步发展受制于各种难以评估的因素;(iv) 公司和无形资产面临安全漏洞的风险;(v) 网络安全威胁可能造成损失或破坏;(vi) 资产市场流动性不足的风险;

(d) 投资估值困难;

(e) Allegory Capital 和 Kainjoo SA 的经营历史有限,不能保证 Allegory Capital 的投资一定会盈利;

(f) Allegory Capital 迄今尚未产生收入,因此无法保证投资回报;

(g) 董事、高级职员和关键员工可从 Allegory Capital 辞职;

(h) Allegory Capital 无法为其面临的所有风险投保;

(i) 与 Allegory Capital 业务有关的法律可能会发生变化,从而对 Allegory Capital 造成不利影响;

(j) Allegory Capital 可能会投资于没有运营历史的实体,这使得对这些实体的评估变得复 杂,并且

(k) 与外汇汇率有关的风险。

Allegory Capital 和 Kainjoo SA 目前不了解或认为不重要的其他风险和不确定因素可能会严重影响其业务、财务状况、估值、交易表现和前景。

因此,建议潜在投资者在对 Allegory Capital 或 Kainjoo SA 做出任何投资决定之前,咨询专门就此类投资提供建议的独立财务顾问。

潜在投资者应根据自身情况和可用财务资源考虑是否适合投资 Allegory Capital 或 Kainjoo SA。